NASDAQ:VTGN - Vistagen Therapeutics Price Target & Analyst Ratings

$0.65
+0.05 (+8.33 %)
(As of 08/22/2019 04:00 PM ET)
Today's Range
$0.56
Now: $0.65
$0.65
50-Day Range
$0.48
MA: $0.59
$0.71
52-Week Range
$0.38
Now: $0.65
$2.44
Volume121,050 shs
Average Volume306,432 shs
Market Capitalization$27.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.19

Analyst Ratings

Vistagen Therapeutics (NASDAQ:VTGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Vistagen Therapeutics in the last 12 months. Their average twelve-month price target is $4.2333, suggesting that the stock has a possible upside of 551.28%. The high price target for VTGN is $6.00 and the low price target for VTGN is $0.70. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.673.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.2333$4.2333$10.00$10.00
Price Target Upside: 551.28% upside582.80% upside1,654.39% upside376.19% upside

Vistagen Therapeutics (NASDAQ:VTGN) Consensus Price Target History

Vistagen Therapeutics (NASDAQ:VTGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/29/2019Chardan CapitalReiterated RatingNeutralHighView Rating Details
5/2/2019Maxim GroupSet Price TargetBuy$6.00HighView Rating Details
11/4/2018OppenheimerSet Price TargetBuy$6.00MediumView Rating Details
5/24/2018UBS GroupInitiated CoverageOutperform$6.00HighView Rating Details
(Data available from 8/22/2017 forward)
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel